This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Alexion Pharmaceuticals, Inc., National Institute of Health and Medical Research. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2026
Title: Jean-Philippe Annereau: Innovator in Ciliopathy Treatments
Introduction
Jean-Philippe Annereau is a notable inventor based in Antony, France. He has made significant contributions to the field of medical research, particularly in the treatment of diseases associated with ciliopathies. His innovative approaches have the potential to impact many lives.
Latest Patents
Jean-Philippe Annereau holds a patent for "Methods for treating diseases associated with ciliopathies." This patent discloses methods of treating a ciliopathy-associated disease by administering an effective amount of a compound that targets at least one G-protein coupled receptor. Additionally, it provides methods for identifying therapeutic agents for treating diseases related to ciliopathies, utilizing an animal model system for testing potential therapeutic agents.
Career Highlights
Throughout his career, Jean-Philippe has worked with prominent organizations such as Alexion Pharmaceuticals, Inc. and the National Institute of Health and Medical Research. His experience in these institutions has allowed him to develop and refine his innovative methods for treating complex diseases.
Collaborations
Jean-Philippe has collaborated with several professionals in his field, including Sophie Saunier and Luis Briseno-Roa. These collaborations have contributed to the advancement of his research and the development of effective treatment methods.
Conclusion
Jean-Philippe Annereau is a pioneering inventor whose work in treating ciliopathy-associated diseases showcases his commitment to medical innovation. His contributions are vital in the ongoing quest for effective therapies in this challenging area of health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile